BILLERICA, Massachusetts – March 2, 2016 – Following its launch at WMIC 2015, Bruker’s new multimodal Albira Si PET/SPECT/CT system has generated considerable interest worldwide, and the company is pleased to announce the first installation at The Texas A&M Institute for Preclinical Studies (TIPS).
The addition of the Albira Si to their array of other instruments, including Bruker’s Xtreme™ optical and X-ray imaging system, supports the TIPS mission of being a leader in translational research and providing comprehensive preclinical research services.
Associate Professor at Texas A&M Gamal Akabani explained: “The paradigm of translational cancer research requires observational modalities that can provide a view of the spatio-temporal pathophysiology of cancer progression and its etiology. There is a significant need for complementary disease models that can elucidate the complex omics interactions and environmental factors that contribute to disease.”
Dr. Akabani continued: “The installation of the Bruker Albira Si, with its superior performance and excellent field of view and accuracy, will complement our translational research capabilities from rodent animal models into natural animal models of cancer. This will enhance the opportunity to understand and expedite the development of diagnostic and therapeutic strategies for cancer and other diseases."
Dr. Wulf I. Jung, President of Bruker’s Preclinical Imaging Division, added: “Bruker shares TIPS’ vision of providing the best possible multi-modal information from animal models for preclinical research to advance discovery and treatment of human diseases. We are confident that the superior PET data from the Albira Si will further enhance TIPS’ capabilities and keep them at the leading edge in this field.”
Preclinical imaging – and PET technology in particular – is aiding researchers as they seek to translate their work in in vivo models to clinical research. However, up to now, sub-millimeter PET image spatial resolution across a wide field of view has not been feasible. With the introduction of the Albira Si, which uses continuous crystal technology with Silicon Photomultiplier readout, this restriction has been removed. In practice, homogenous sub-millimeter volumetric PET resolution is now delivered on all three axes across the entire field of view. Advanced depth-of-interaction detection enables precise 3D localization of events without the limitations of conventional crystals configured in discrete layers. The result is superior resolution and consistent quantification in an area up to 5 times larger than for conventional preclinical PET systems, providing unprecedented image clarity. By introducing this new technology in its proven multimodal Albira platform, Bruker now offers even better image co-registration.
For more information on Bruker’s range of preclinical imaging platforms visit: www.bruker.com/preclinicalimaging
About Bruker Corporation
For more than 50 years, Bruker has enabled scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific research instruments and high-value analytical solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels.
In close cooperation with our customers, Bruker is enabling innovation, productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy, nano-analysis and industrial applications, as well as in cell biology, preclinical imaging, clinical research, microbiology and molecular diagnostics.
For more information, please visit: www.bruker.com.
About The Texas A&M Institute for Preclinical Studies (TIPS)
TIPS provides large animal Good Laboratory Practices (GLP) and translational research studies with unique access to expertise in all major medical and scientific disciplines including surgery, biomedical engineering, advanced imaging, pathology, radiography, interventional cardiology, neurology, animal behavior, chemistry, and engineering.
With unique resources and collaboration with the Texas A&M College of Veterinary Medicine and Biomedical Sciences, TIPS facilitates the inclusion of animals with naturally occurring disease as viable research models. TIPS provides unique opportunities to develop new therapeutics in the fields of oncology, cardiology, immunology, endocrinology, and an array of genetic disorders common to humans and companion animals. For more information, please visit: http://tips.tamu.edu/
Dr. Thorsten Thiel
Director of Marketing Communications
T: +49 (721) 5161-6500
Gamal Akabani, PhD.
Associate Professor and Senator
Texas A&M University
T: +1 (979)-458-1699